Pictured are some of the members of the Sterling Lions Club Parkinson’s Exercise Group. Because exercise is known to be the ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease ...

Parkinson’s disease (PD ... In some cases, these can potentially slow disease progression. Studies show that moderate to vigorous cardiovascular exercise can slow disease progression ...

Northern Arizona University (NAU) is offering a free weekly movement class this fall for those dealing with Parkinson’s disease ... has shown that regular exercise and social interaction ...

Sprenger Healthcare Elms Retirement Village is accepting sign-ups for a Take Control with Total Parkinson’s exercise class ...

The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...

exercise and community to people with Parkinson’s in the New Orleans area. Parkinson’s disease is a neurodegenerative disorder that affects predominantly dopamine-producing neurons in the brain.

Alzheimer’s disease and Parkinson’s disease are both neurodegenerative diseases. They’re similar in terms of symptoms, treatment, risk factors, and outlook. But there are also differences.

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

“Genetic variants associated with larger brain volumes in key brain regions also increase the risk of Parkinson’s disease, while variants linked to smaller brain volumes in key regions are ...

Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...